Results 131 to 140 of about 22,079 (225)

Frontotemporal lobar degeneration therapeutic development pipeline: 2026

open access: yesAlzheimer's &Dementia: Translational Research &Clinical Interventions, Volume 12, Issue 4, October/December 2026.
Abstract INTRODUCTION Frontotemporal lobar degeneration (FTLD) comprises a group of neuropathological entities underlying a spectrum of clinical syndromes, including behavioral variant frontotemporal dementia, the primary progressive aphasias, progressive supranuclear palsy, and corticobasal syndrome.
Alberto Benussi   +16 more
wiley   +1 more source

Clinical and genetic analysis of MAPT, GRN, and C9orf72 genes in Korean patients with frontotemporal dementia

open access: yes, 2018
C9orf72; Frontotemporal dementia; GRN; Korean; MAPT ...
정지향
core   +1 more source

Genome‐Wide Association Studies of Hospitalized Influenza Identify Four Risk Loci and Reveal Shared and Unique Genetic Factors Compared With COVID‐19

open access: yesInfluenza and Other Respiratory Viruses, Volume 20, Issue 10, October 2026.
ABSTRACT Background Influenza remains a significant global health burden, potentially leading to hospitalization and mortality. Although previous studies have explored genetic susceptibility to influenza infection, the genetic basis of influenza hospitalization and its relationship with respiratory diseases like COVID‐19 remain poorly understood ...
Xiao Xue   +4 more
wiley   +1 more source

CTE MAPT subhaplotypes

open access: yes
Structural haplotypes in the 17q21.31 MAPT region and Chronic Traumatic Encephalopathy ...
Xudong Han
core  

Characterization of the brain lipidome associated with frontotemporal lobar degeneration MAPT P301S mutation

open access: yesJournal of Lipid Research
Mutations in microtubule-associated protein Tau (MAPT), the gene that codes for the protein Tau, cause frontotemporal lobar degeneration (FTLD) with phenotypes ranging from behavioral changes to cognitive impairment and parkinsonism.
Almudena Maroto-Juanes   +6 more
doaj   +1 more source

MAPT p.V363I mutation: A rare cause of corticobasal degeneration [PDF]

open access: yes, 2019
Objective: Patients with corticobasal syndrome (CBS) present with heterogeneous clinical features, including asymmetric parkinsonism, dyspraxia, aphasia, and cognitive impairment; to better understand the genetic etiology of this rare disease, we ...
Pastor, P   +16 more
core   +1 more source

Nimodipine Improves Cognitive Impairment After Subarachnoid Hemorrhage in Rats Through IncRNA NEAT1/miR-27a/MAPT Axis

open access: yesDrug Design, Development and Therapy, 2020
Jun-Wei Li, Shao-Hua Ren, Jin-Rui Ren, Zi-Gang Zhen, Li-Rong Li, Xu-Dong Hao, Hong-Ming Ji Department of Neurosurgery, The People’s Hospital of Shanxi Province, Taiyuan, Shanxi Province, People’s Republic of ChinaCorrespondence: Hong-Ming Ji ...
Li JW   +6 more
doaj  

A novel MAPT variant (E342K) as a cause of familial progressive supranuclear palsy

open access: yesFrontiers in Neurology
BackgroundMAPT variants are a known cause of frontotemporal dementia and Parkinsonian syndrome, of which progressive supranuclear palsy syndrome (PSP) is a rare manifestation.ObjectiveTo report a novel MAPT variant in a PSP pedigree with autosomal ...
Hang Li   +7 more
doaj   +1 more source

MAPT Subhaplotypes in Different Progressive Supranuclear Palsy Phenotypes

open access: yesBiomedicines
Background: Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder characterized by abnormal tau protein aggregation. The MAPT gene encodes for tau protein.
Monica Gagliardi   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy